We are very pleased to announce the Sixth International Fluid Academy Days, which will take place on November 23-25th 2017 at the Hilton Hotel in Antwerp, Belgium.
The aim of this sixth edition is again to review recent advances in fluid management, and hemodynamic and organ function monitoring in the critical care setting in a comprehensive manner for intensivists, anaesthesiologists and emergency physicians as well as interested internists and surgeons. However the meeting will deal with any broad topic related to critical care. As always it is also a great way to promote professional interaction between faculty members, participants and delegates of the industry.
This website does not accept nor host any advertisement.
Download the information brochure here
A passion for medical technology and ensuring the availability of optimal total solutions in all circumstances. Acertys, as a partner for hospitals and medical professionals, only wants what is best for both staff and patients.
Our products comprise the medication needed to relieve symptoms and significantly improve the quality of life, as well as medication that is primarily used in critical, life-threatening situations. That is why we maintain constant communication with medical specialists and focus on the real needs in medical practice to develop products in line with actual clinical requirements.
Highest quality standards, delivery reliability and a strong drive to excel as a team are fundamentally important to us. We act swiftly and flexibly to find the right solutions – in close consultation with medical specialists and for the benefit of patients. We share the responsibility for the smooth functioning of medical measures at the decisive moment. Whether owner or team members - at AMOMED Pharma, we are fully aware of the importance of our actions and are deeply committed to the far-reaching aspect of our work.
B. Braun supports the International Fluid Academy first of all because of their mutual interest in fluid management. Therefore you can find us at our booth during the 6th International Fluid Academy Days November 2017 in Antwerp. Our B. Braun colleagues are more than willing to share expertise about the recent developments in fluid management!
Who is B. Braun? B. Braun is one of the world's leading providers of healthcare products today. We supply the global healthcare market with products and systems for anesthesia, intensive care, cardiology, extracorporeal blood treatment and surgery. We also provide services for clinics, physicians in private practices and the home care sector.
Baxter develops, manufactures and markets products and therapies that save and sustain the lives of people with hemophilia, immune disorders, cancers, kidney disease, malnutrition and other acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in pharmaceuticals, biotechnology and medical devices to create products that advance patient care worldwide.
A mission to improve patient safety and outcomes
We design and build products for patient simulation, surgical simulation, ultrasound simulation and clinical simulation management. CAE Healthcare is committed to advancing medical training and education for today’s healthcare practitioners and learners. We develop simulation-based technologies, curriculum and resources that improve clinical performance. With an emphasis on innovative solutions, simulation expertise and world class support, we deliver products and services to help prepare interprofessional clinical teams. Our solutions are designed to improve confidence, competency and teamwork for better patient outcomes. In 2017, CAE is celebrating its 70th anniversary. Over the last few decades, to shape the future of training, we’ve built on our diversity, our passion for excellence, and the talent of our employees all over the world. We may be many, but we succeed as one. One CAE!
CAF-DCF is een Belgische vennootschap, die zich gespecialiseerd heeft in de productie van stabiele plasmaderivaten: stollingsfactoren, immunoglobulinen en albumine oplossingen. Voor de bereiding van deze plasmaderivaten voor de Belgische gezondheidszorg, wordt plasma gebruikt, afgenomen bij vrijwillige en onbetaalde donoren. De inzet van dit bloedplasma afgestaan door de donor en de aanmaak van producten voor patiënten vormen de hoeksteen van een "human to human approach".
Created in 2001, congres-medical.com is the first platform referencing and promoting medical events. Congres-medical.com is also a directory listing of websites, sites and companies providing the event. The site offers publishing tools allowing members to announce, reference, share, broadcast content moderated and validated by the team of congres-medical.com in the field of health, (Congress, Congress exhibition venues, event service providers, medical providers,...). Under "News" has become a directory of content aggregation and distribution of information. "RSS (Really Simple Syndication)" is the new standard for exchange of content. It is performed by a professional team in partnership with info-live.com (French version). The ambition of writing congres-medical.com is to inform users and professionals independently with great attention to quality and reliability. The editorial team runs, detects, moderates, validates and distribute all the contents on social network and partner websites. For communication without borders ! Thank you for your attention and loyalty. **congres-medical.com is totally free**
ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key focus areas - Ostomy Care, Wound Therapeutics, Continence and Critical Care and Infusion Devices - ConvaTec products support healthcare professionals from the hospital to the community health setting. For more information, please visit: www.convatec.com.
A global pioneer in medical breakthroughs, Cook Medical is committed to creating effective solutions that benefit millions of patients worldwide. Today, we combine medical devices, drugs, biologic grafts and cell therapies across more than 16,000 products serving more than 40 medical specialties. Founded in 1963 by a visionary who put patient needs and ethical business practices first, Cook is a family-owned company that has created more than 10,000 jobs worldwide. For more information, visit our website.
C. R. Bard, Inc. (Bard) is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company operates through the manufacture and sale of medical devices segment. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. Its vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and end-stage renal disease. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers, and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and soft tissue repairs.
Proud disseminating the great work of others
Critical Care Northampton is an online resource for all that is FOAMed / FOAMcc and of course POCUS. We have an ever expanding following with a growing team and provide weekly updates on what is big and being talked about within Critical Care. Our other aim is to provide a wealth of useful resources; to download, learn from and teach with. We also feature regular blogs on hot topics / areas of controversy welcoming guest publishers. We pride ourselves in disseminating the great work of others, whether web based or not, and continue to expand this network so others may benefit from it. The International Fluid Academy is just one of those links we are very proud to have.
CytoSorbents is a critical care immunotherapy company commercializing its CE approved CytoSorb, a safe and effective cytokine adsorber. CytoSorb is designed to attenuate the dysregulated, hyperinflammatory response („cytokine storm“) present in septic shock and other, non-infectious systemic hyperinflammatory states by reducing elevated levels of cytokines and other inflammatory mediators. This modulation of the immune response can lead to an improvement of hemodynamics, a reduction in the need for vasopressors and overall to an increased chance for recovery of organ functions and improved patient outcomes. CytoSorb is indicated in various hyperinflammatory states of infectious and non-infectious origin, e.g. after cardiac surgery, in cardiogenic shock, trauma, burns, pancreatitis and infection. So far it has been used safely and well tolerated in more than 27,000 single treatments worldwide. CytoSorb Therapy – REGAIN CONTROL!
Turn your data into an interactive data story report
DataStories International NV is an award-winning advanced predictive analytics company based in Turnhout, Belgium. Our AI-based automated analytics platform automatically analyzes relationships in spreadsheet data, builds forecasts and creates interactive what-of scenarios. With DataStories you can take data from various sources such as risk and safety, medical treatment statistics, experimental R&D, life sciences or sales, and distill the minimum number of variables needed to optimally your predict target variables and KPIs. The results are presented in an interactive narrative, a story about your data.
"We do everything we do with passion - and we do it for life." (Stefan Drager, Executive Board Chairman)
As an international leader in medical and safety technology, Drager develops innovative equipment and solutions that people all over the world over trust when lives are on the line. Our medical division's product range covers anesthesia workstations, ventilation equipment for intensive care, emergency, neonatal and mobile ventilation units, warming therapy equipment for infants, patient monitoring equipment, IT solutions, architectural systems and gas management systems.
Edwards Lifesciences has been advancing the care of the acutely ill for over 40 years. We are focused on helping clinicians enhance knowledge and standardize practice to improve the quality and efficiency of care. Edwards is dedicated to providing evidence-based medicine programs such as the Enhanced Surgical Recovery Program that facilitates the implementation and compliance of protocolized care in the OR in order to reduce post-surgical complications. Edwards also offers a range of advanced monitoring tools – including noninvasive to minimally-invasive hemodynamic monitoring and continuous glucose monitoring – expansive educational resources, and clinical support to ensure sustained compliance.
Epimed Solutions is specialised in management solutions for clinical and epidemiological information, which enable improvements to efficiency of hospital care and patient safety. Founded in 2008 by intensive care physicians with wide experience in risk and prognostic studies, Epimed Solutions is a market leader and is currently present in more than 450 hospitals in Europe and Latin America. Following its mission and values, Epimed offers innovative and exclusive solutions which aim to increase the efficiency of hospitals.
Esaote is one of the world’s leading producers of medical diagnostic systems and internationally acknowledged to be the world leader in dedicated MRI. The Esaote Group is also one of the main players in the sector of Information Technology for healthcare.
An Open Access Journal on Fluids
Fluids (ISSN 2311-5521) is an open access journal, which provides an advanced forum for studies on fluid dynamic theory and its applications, and fluid simulation, modeling and experimentation in chemical, physical and biological processes. Our aim is to publish state-of-the-art papers, including original research papers, reviews, case reports, as well as technical notes and meeting reports. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.
Fluids is a member of the Committee on Publication Ethics (COPE). MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications. MDPI works with Publons to provide reviewers with credit for their work.
Fresenius Kabi is the leader in infusion therapy and clinical nutrition in Europe and in most important countries of Latin America and Asia Pacific. Within I.V. generic drugs, Fresenius Kabi counts among the leading suppliers in the U.S. market. All over the world more than 24,000 employees are committed to improving the quality of life of critically and chronically ill patients with innovative products for patients in hospitals and outpatients.
Fresenius Medical Care (FME) offers services & products in more than 120 countries and cares for more than 310,000 patients in our global network of more than 3,600 dialysis clinics. At the same time, we operate 37 production sites on all continents, to provide dialysis products such as dialysis machines, dialyzers and related disposables.
Offering a variety of therapies, Fresenius Medical Care provides efficient treatment of acute kidney injury to fit each patient's specific needs. Besides the several options for CRRT, Fresenius Medical Care also provides options for plasmapheresis and therapeutic apheresis.
Therapeutic apheresis is a therapy for removing pathogenic substances from blood using filters and adsorbers. With a portfolio of different adsorbers and long-standing expertise in extracorporeal procedures, Fresenius Medical Care delivers a combination of quality and flexible treatment alternatives, designed to treat a wide range of diseases and increase the patient’s quality of life.
In January 2017, Fresenius Medical Care acquired the Xenios company. Xenios offers minimally invasive disposable lung and heart therapies on one single platform. This acquisition is an opportunity to expand FME’s position as the global leader in extracorporeal organ support.
SonoSite, Inc. (www.sonosite.com ), a subsidiary of FUJIFILM, is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. Size is everything for SonoSite. The firm makes handheld ultrasonic imaging devices that health care providers can use outside traditional imaging facilities, for instance, in the ER, at a patient's bedside, or in the doctor's office. Its fourth- and fifth-generation systems include the handheld NanoMaxx tool and the M-Turbo and Edge portable consoles that produce imaging quality comparable to larger cart-based systems. Its S Series of products feature customized interfaces for different clinical applications, including the ER or the ICU.
The critical condition of the ICU patient requires sage, efficient and flexible therapeutic options. Gambro has used its know how in blood purification to develop innovative concepts to offer treatments for renal and liver failure.
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.
Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to morepeople around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.
Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world.
Getinge AB is a Sweden-based company active in the healthcare sector. It provides products and services for intensive care units, sterilization centers, elderly care and companies and institutions active in the life sciences area. Its operations are divided into three business areas: The Medical Systems business area offers equipment for surgical disciplines, cardiology and intensive care; the Extended Care business area offers products and services geared toward the hospital and elderly care markets, including solutions for preventing the risk of pressure ulcers and deep vein thrombosis, and the Infection Control business area features systems for preventing the occurrence and spread of infection. Its products comprise disinfectors, sterilizers, including low temperature sterilization solutions, information technology (IT) solutions, as well as advice, training and technical support. The Company's products are sold under the Getinge, Lancer, ArjoHuntleigh and MAQUET brands.
In the early 50's, Mr Henry Nootens was already active in the World of the hospitals. In 1957 he founded, together with his wife Mrs Gilberte Poels, the company named H. Nootens SA. Those days, the fundamentals of the gamma of hospitalization were made. The range of products contained needles and syringes, sterilization boxes, urologic catheters, endotracheal tubes, all kinds o bandages etc.
Their Son, Jean-Jacques Nootens, enters the family company in 1968 and he decides to create the surgical department. This department offers a range of products for the use in the OR: surgical instruments, instruments for thoracic drainage, orthopedic en ophthalmologic implants. Mr Andre Lombarts starts in 1978 as the head of the department of hospitalization and as the chief of finances. In 1995, Mrs Valerie-Anne Nootens starts in the company to improve the impact of marketing. In 1998 she becomes the head of quality care. Pierre-Henri Nootens joins the team in 2002 and he takes care of the stocks of our different suppliers.
These days, our team of 12 specialized representatives visits the hospitals on daily basis. The group Hospiplan-Nootens was erected in 1996 to adept the activities better to the reality of the European market. Nowadays, Hospiplan focuses on the commercialization of the new products which demand optimalization following the Belgian and Luxembourgian specificities.
Philosophy of the company
H Nootens SA became well known thanks to the good quality of service to the world of surgery and hospitals. Following our philosophy, we are convinced that it is important to listen very carefully to the needs of our clients to give a good service. Thanks to a good management of our stock, we are able to supply most of our orders of common products to the hospitals in a small amount of time. During 2004, efforts in the area of Quality Care made it possible to acquire the certificate ISO 9001-2000 and EN 13485:2003.
The InBody S10™ is a body composition analyzer that can be used in bedded patients for fluid management and nutritional assessment in critical care. InBody’s Direct Segmental Multi-frequency Bioelectric Impedance Analysis (DSM-BIA) technology and exclusion of empirical estimations allow InBody devices to achieve extremely high levels of accuracy and reproducibility, and the non-invasive nature of BIA procedures makes testing on an InBody device simple and convenient. InBody provides a comprehensive breakdown of body composition by giving a wide range of outputs including basic body composition parameters such as, Total Body Water, Percent Body Fat, Lean Body Mass, Skeletal Muscle Mass, BMI, and advanced nutritional assessment parameters, Phase Angle, Body Cell Mass and much more. Recently InBody has been used in dialysis center for dry weight, and also in ICUs for nutritional assessment and severity assessment using segmental ECW ratio and segmental Phase Angle.
Laerdal is one of the world’s premiere vendors of medical simulation and clinical education equipment. Laerdal began their mission to “help save lives” in 1960 with the invention of the CPR training manikin called Resusci Anne. For over fifty years, Laerdal Medical has provided the global healthcare community with clinical task training and high fidelity manikin products ranging from the Laerdal pocket mask to the Laerdal SimMan. The company boasts more than 1400 employees in over 20 countries with as many as 50 international distributors. Laerdal has partnered with key medical and public healthcare societies, such as the American Heart Association and the National League for Nursing, to provide educational curriculum for healthcare students and professionals. To provide easy access to these simulation scenarios, Laerdal has teamed up with HealthStream to develop SimCenter – an online learning management system that can provide educational solutions for your medical simulation center. Laerdal Medical supports healthcare education training in a range of fields including EMS, military, hospital, nursing, and voluntary organizations just to name a few.
Maltron is a leading manufacturer of Bio-electrical and Electrical Impedance Tomography used in the assessments of Body and Abdominal Composition, Malnutrition, Fluid Monitoring and for monitoring lung diseases bedside by leading hospitals and institute worldwide. The company focus is on the research, development, manufacture and marketing of innovative products. Maltron products are well known for quality, reliability and consistent reproducibility providing reliable assessment of Body Composition and hydration in a simple, safe and scientific manner.
Maquet, a trusted partner for hospitals and physicians for more than 175 years, is a global leader in medical systems. The company offers innovative therapy solutions and infraY structure capabilities for highYacuity areas within the hospital Y including the operating room, hybrid OR, and intensive care unit Y as well as intraY and interYhospital patient transport. Additionally, Maquet develops intelligent and sustainable room concepts that exceed the expectations of modern hospitals, working in close cooperation with customers, production engineers and architects to integrate high quality products and services. Headquartered in Rastatt, Germany, Maquet is the largest subsidiary of the publicly listed Getinge Group AB of Sweden. Maquet generated about 1.55 billion Euros in 2014, representing more than half of the Getinge Group’s annual revenue of 2.93 billion Euros. Maquet has around 7,000 employees and provides 53 international sales and service organizations. Maquet is The Gold Standard. For more information, please visit www.maquet.com.
Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. A key medical technology innovator, Masimo is responsible for the invention of award-winning noninvasive technologies that are revolutionizing patient monitoring, including Masimo SET® pulse oximetry, Masimo Rainbow Pulse CO-Oximetry and new Masimo noninvasive and continuous total hemoglobin (SpHb™) monitoring technology. The recent introduction of the first-and-only FDA-cleared technology that noninvasively and continuously measures total hemoglobin without a painful needle stick and invasive blood draw is expected to open new markets and significantly expand the company’s growth opportunities.
MTT is specialised in non-invasive monitoring of Ventilation and Perfusion. The Evidence Based Monitoring technology for Hemodynamic optimization of IC and OR patients, the Oesophagale Doppler Monitor ODM.
ODM-guided fluid management is a cornerstone of Enhanced Recovery, delivering better quality, more cost effective care as it means patients recover from their surgery faster and leave hospital sooner and in better health than they otherwise would do.
What NICE said about Cardio-Q Doppler
". . .The case for adopting the CardioQ-ODM in the NHS,. . .is supported by the evidence. . .The CardioQ ODM should be considered for use in patients undergoing major or high-risk surgery or other surgical patients in whom a clinician would consider using invasive cardiovascular monitoring. This will include patients undergoing major or high-risk surgery or high risk patients undergoing intermediate-risk surgery." NICE: Medical Technology guidance 3. National Institute for Health and Clinical Excellent, March 2011.
Medical Technology Transfer is founded in 1993 and has the ambition to effectively support medical practice and medical treatment with carefully selected, evidence based technologies.
MTT focuses on the introduction, delivery and maintenance of directly applicable clinical measuring, monitoring and respiratory equipment and related systems with high added value. Neonatology, developmental care and optimal care of the heart and lung function are focus points.
At the same time is an excellent support to both doctors and nurses as well as medical physicists and medical technicians a high priority. Hereto MTT offers training standard with procurement of a system and a telephone helpline 24 hours, seven days a week available for user questions and emergency support.
Also the short and long term rental of systems belongs to the possibilities. The "budget save rent" is developed together with some major clients and is frequently asked for nowadays.
MTT supports medical research and promotes the exchange of knowledge and experience between users and manufacturers.
Orion is a globally operating Finnish company developing pharmaceuticals and diagnostic tests, a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. Pharmaceutical R&D focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler ® pulmonary drugs.
At Pfizer, we apply science and use our global resources to improve health and well-being at every stage of life. Consistent with our responsibility as the leading biopharmaceutical company, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care. Our 2000 colleagues in Belgium work in all stages of drug development. The production plant at Puurs and the Phase I Clinical Research Unit in Brussels are worldwide recognized for their expertise in innovation.
Philips Medical Systems consists of patient monitoring and clinical information systems, automated external defibrillators, such as HeartStrart, and electrocardiography. These products are targeted at health providers including hospitals, outpatient clinic, physician offices, emergency rooms, and home-health services.
www.propofology.com is an UK based, international project created out of the desire to advance FOAMed (Free Open Access to Medical Education) to everyone involved in anaesthesia, critical care and pain medicine. The website focuses on delivering ‘infograms’, or small graphic tutorials on topics pertinent to these fields; aiming to distill complicated topics into short ‘bytes'. There are over one hundred infographics to peruse and learn from as well as a medical student section, opinion articles and signposts. There is also an expanding collection of YouTube videos, so be sure to subscribe to the YouTube channel to keep up to date! The content is disseminated on Twitter to the #FOAMed network and is particularly useful not only for those practicing in anaesthesia and critical care, but also individuals revising for specialty and medical school examinations.
Founded more than 20 years ago in Munich Germany, Pulsion has become a leading specialist in haemodynamic monitoring and provides the clinician with a variety of technologies to optimise the haemodynamic management of patients in ICU and in the OR; transpulmonary thermodilution technique for cardiac output, preload and lung water measurements (PiCCO); fibreoptic continuous measurement of the central venous oxygen saturation via standard CVC (CeVOX); non-invasive evaluation of the liver function and splanchnic perfusion with indocyanine green dye (LiMON); non-calibrated CO trend measurement via standard arterial line (ProAQT); and the PulsioFlex monitoring platform with the modular concept to enable patient centred flexibility.
Social Media and Critical Care
SMACC is a FOAMed charity that promotes education and knowledge sharing in Critical Care. They also host an epic conference! SMACC (Social Media and Critical Care) is a health promotion charity. It is based on the philosophy of FOAM (Free Open Access Medical education – #FOAMed). The organising committee gives their time freely and receives no financial benefit. This in part explains the wonderful passions for philanthropy, sharing, education and innovation that make this critical care community so unique.
SMACC has seen spectacular growth since its humble beginnings. The Conference has grown from an enthusiastic idea into a global leader amongst critical care events. Whilst SMACC is primarily a high quality, academic meeting, the real reason behind this growth is the enormous and inspiring energy of the critical care community itself. SMACC crosses traditional hierarchies, professional barriers and international borders. It is a community that is centered on the pursuit of excellence in patient care and a passion for sharing this as widely as possible.
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides branded specialty medicines for use in central nervous system and respiratory indications, as well as the womens health, oncology, and other specialty businesses. Its products in the central nervous system area comprise Copaxone for multiple sclerosis; Azilect for the treatment of Parkinsons disease; and Nuvigil for the treatment of excessive sleepiness associated with narcolepsy and certain other disorders. This segments products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Treanda/Bendeka, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. This segment also offers a portfolio of products in the womens health category, which includes ParaGard, Plan B One-Step, and OTC/Rx, as well as other products. The company has collaboration arrangements with Attenukine, Procter & Gamble Company, and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.
Stay tuned with the latest publications
Welcome to The Bottom Line (TBL). This site has been built to create a compendium of all the landmark papers which are shaping the way we manage our critically ill patients. Each paper has been summarised and critiqued using a standard template and ends with a 'bottom line' paragraph to allow a quick reminder of the key points. The papers are reviewed and cross checked by the editorial group. We take this seriously and spend time getting it accurate and as helpful for our readers as possible. If you think we have got it wrong, please let us know or use it as a discussion in the comments section. The main value of this site is the discussion of these papers and the contribution of the global FOAM community. We hope you enjoy!
Advancing medical practice
The Wessex Intensive Care Society (WICS) was established in the 1980's. It has rapidly developed into a society which brings together intensive care health professionals across the Wessex region.
Our aim is to advance medical practice within our intensive care units and hospitals and provide supportive training and quality education.
XENIOS’ novalung iLA, i–cor, and medos devices
XENIOS is the therapy and technology leader in minimally invasive lung and heart assist. XENIOS’ novalung iLA, i–cor, and medos devices provide pulmonary and cardiac assist for a broad range of support levels on the unique XENIOS platform. XENIOS’ novalung iLA therapy is an adjunct or an alternative to injurious, immobilizing mechanical ventilation. XENIOS i-cor therapy is a novel less invasive heart assist therapy synchronized with the human heartbeat. These therapies enable caregivers to keep lung failure patients awake, self-determined and mobile while preventing ventilator-associated lung injury, pneumonia, and breathing muscle damage.